JP Patent

JP4377962B2 — 抗癌剤として有用なトリアゾロピラジン誘導体

Assigned to ファイザー・プロダクツ・インク · Expires 2009-12-02 · 16y expired

What this patent protects

Patent listed against quizartinib-dihydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP4377962B2
Jurisdiction
JP
Classification
—
Expires
2009-12-02
Drug substance claim
No
Drug product claim
No
Assignee
ファイザー・プロダクツ・インク
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.